ягоды, зеленый чай и гвоздика.
Чтобы получить основные питательные вещества, необходимые моему мозгу для выработки энергии и ее использования для работы, я принимаю витаминно-минеральную добавку и концентрированный рыбий жир.
Я добавляю продукты, богатые ацетилхолином, например, креветки.
Я буду поддерживать связь с другими людьми и заниматься волонтерством, чтобы избежать одиночества и изоляции.
Я начну или продолжу заниматься музыкой. [248]
Сегодня я начну ежедневно учиться новому.
[205] Daniel G. Amen et al., "Patterns of Regional Cerebral Blood Flow as a Function of Age throughout the Lifespan," Journal of Alzheimer's Disease 65, no. 4 (2018): 1087-92.
[206] D. J. Hare et al., "Is Early-Life Iron Exposure Critical in Neurodegeneration?" Nature Reviews Neurology 11, № 9 (сентябрь 2015 г.): 536-44.
[207] R. McClelland et al., "Accelerated Ageing and Renal Dysfunction Links Lower Socioeconomic Status and Dietary Phosphate Intake," Aging 8, no. 5 (May 2016): 1135-49.
[208] L. E. Hebert et al., "Change in Risk of Alzheimer Disease Over Time," Neurology 75, no. 9 (August 31, 2010): 786-91.
[209] "Психическое здоровье пожилых людей", Всемирная организация здравоохранения, 12 декабря 2017 г., www.who.int/news-room/fact-sheets/detail/mental-health-of-older-adults.
[210] W. Cai et al., "Oral Glycotoxins Are a Modifiable Cause of Dementia and the Metabolic Syndrome in Mice and Humans," Proceedings of the National Academy of Sciences of the United States of America 111, no. 13 (April 1, 2014): 4940-45.
[211] "Национальный опрос о здоровом старении", Мичиганский университет (март 2019 г.), ihpi.umich.edu/sites/default/files/2019-03/NPHA_Loneliness-Report_FINAL-022619.pdf.
[212] Gabriel H. Sahlgren, "Work Longer, Live Healthier," IEA discussion paper no. 46 (May 2013), http://iea.org.uk/sites/default/files/publications/files/Work%20Longer,%20Live_Healthier.pdf.
[213] Kapil Sayal et al., "Relative Age within the School Year and Diagnosis of Attention-Deficit Hyperactivity Disorder: A Nationwide Population-Based Study," Lancet Psychiatry 4, № 11 (November 1, 2017): 868-75.
[214] Corey L. M. Keyes, "Authentic Purpose: The Spiritual Infrastructure of Life," Journal of Management, Spirituality & Religion 8, no. 4 (November 2011): 281-97.
[215] P. A. Boyle, et al., "Effect of Purpose in Life on Risk of Incident Alzheimer Disease and Mild Cognitive Impairment in Community-Dwelling Older Persons," Archives of General Psychiatry 67, no. 3 (March 2010): 304-10.
[216] T. J. Holwerda et al., "Feelings of Loneliness, but Not Social Isolation, Predict Dementia Onset: Results from the Amsterdam Study of the Elderly (AMSTEL)", Journal of Neurology, Neurosurgery, and Psychiatry 85, no. 2 (February 2014): 135-42.
[217] "Loneliness on the RISE: One in Eight People Have No Close Friends to Turn To", Express, March 1, 2017, http://www.express.co.uk/news/uk/773002/One-in-eight-people-faced-with-loneliness.
[218] Kira Asatryan, "4 Disorders That May Thrive on Loneliness," Psychology Today, July 23, 2015, https://www.psychologytoday.com/us/blog/the-art-closeness/201507/4-disorders-may-thrive-loneliness.
[219] E. E. Lee et al., "High Prevalence and Adverse Health Effects of Loneliness in Community-Dwelling Adults across the Lifespan: Role of Wisdom as a Protective Factor", International Psychogeriatrics (published online December 18, 2018): 1-16.
[220] S. Korkmaz et al., "Частота анемии у пациентов с хронической психиатрией", Neuropsychiatric Disease and Treatment 11 (October 22, 2015): 2737-41.
[221] Джозеф Меркола, "Железо: этот спасительный минерал, как выяснилось, на самом деле увеличивает старческий маразм у многих", Меркола, 19 июля 2012 года, http://articles.mercola.com/sites/articles/archive/2012/07/19/excess-iron-leads-to-alzheimers.aspx#_edn1.
D. J. Hare et al., "Is Early-Life Iron Exposure Critical in Neurodegeneration?".
A. C. Leskovjan et al., "Increased Brain Iron Coincides with Early Plaque Formation in a Mouse Model of Alzheimer's Disease," Neuroimage 55, no. 1 (March 1, 2011): 32-38.
[222] C. C. Meltzer et al., "Serotonin in Aging, Late-Life Depression, and Alzheimer's Disease: The Emerging Role of Functional Imaging," Neuropsychopharmacology 18, no. 6 (June 1998): 407-30.
[223] S. E. Hemby et al., "Neuron-Specific Age-Related Decreases in Dopamine Receptor Subtype mRNAs," Journal of Comparative Neurology 456, no. 2 (February 3, 2003): 176-83.
Жан-Клод Дреер и др., "Возрастные изменения дофаминергической регуляции системы вознаграждения в среднем мозге человека", Proceedings of the National Academy of Sciences of the United States of America 105, no. 39 (September 30, 2008): 15,106-11.
[224] Томас Макнилл и Майкл Яковец, "Нейротрансмиттеры: ГАМК и глутамат", Медицинская энциклопедия (2019), http://medicine.jrank.org/pages/1225/Neurotransmitters-GABA-glutamate.html.
[225] J. L. Muir, "Acetylcholine, Aging, and Alzheimer's Disease," Pharmacology, Biochemistry, and Behavior 56, no. 4 (April 1997): 687-96.
[226] John Hiscock, "Judi Dench Interview: 'Retirement Is a Rude Word'," Telegraph, February 21, 2015, https://www.telegraph.co.uk/culture/film/film-news/11420407/Judi-Dench-interview-second-exotic-marigold-hotel.html.
[227] S. Samman et al., "Green Tea or Rosemary Extract Added to Foods Reduches Nonheme-Iron Absorption," American Journal of Clinical Nutrition 73, no. 3 (March 2001): 607-12.
[228] Y. Jiao et al., "Хелатирование железа в биологической активности куркумина", Free Radical Biology and Medicine 40, no. 7 (1 апреля 2006 г.): 1152-60.
[229] Sonja Hilbrand et al., "Caregiving within and beyond the Family Is Associated with Lower Mortality for the Caregiver: A Prospective Study," Evolution and Human Behavior 38, no. 3 (May 2017): 397-403.
[230] M. C. Carlson et al., "Impact of the Baltimore Experience Corps Trial on Cortical and Hippocampal Volumes," Alzheimer's and Dementia 11, no. 11 (November 2015): 1340-48.
[231] O. Dean et al., "N-ацетилцистеин в психиатрии: Современные терапевтические данные и потенциальные механизмы действия", Журнал психиатрии и нейронаук 36, № 2 (март 2011 г.): 78-86.
[232] Ibid.
[233] J. C. Adair et al., "Controlled Trial of N-acetylcysteine for Patients with Probable Alzheimer's Disease," Neurology 57, no. 8 (October 23, 2001): 1515-17.
W. R. Shankle et al., "CerefolinNAC Therapy of Hyperhomocysteinemia Delays Cortical and White Matter Atrophy in Alzheimer's Disease and Cerebrovascular Disease," Journal of Alzheimer's Disease 54, no. 3 (October 4, 2016): 1073-84.
[234] Wei Zheng et al., "Huperzine A for Treatment of Cognitive Impairment in Major Depressive Disorder: A Systematic Review of Randomized Controlled Trials," Shanghai Archives of Psychiatry 28, no. 2 (April 25, 2016): 64-71.
[235] Wei Zheng et al., "Adjunctive Huperzine A for Cognitive Deficits in Schizophrenia: A Systematic Review and Meta-Analysis," Human Psychopharmacology 31, no. 4 (July 2016): 286-95.
[236] B. S. Wang et al., "Efficacy and Safety of Natural Acetylcholinesterase Inhibitor Huperzine A in the Treatment of Alzheimer's Disease: An Updated Meta-Analysis," Journal of Neural Transmission 116, no. 4 (April 2009): 457-65.
[237] H. A. Hausenblas et al., "Saffron (Crocus sativus L.) and Major Depressive Disorder: A Meta-Analysis
